Results 131 to 140 of about 8,366 (155)

Klebsiella pneumoniae Carbapenemase Variants Resistant to Ceftazidime-Avibactam: an Evolutionary Overview

Antimicrobial Agents and Chemotherapy, 2022
Beatrice Bercot, André Birgy
exaly  

Ceftazidime–Avibactam Sodium

2021
openaire   +1 more source

Molecular analysis of clinical isolates of ceftazidime-avibactam-resistant Klebsiella pneumoniae

Clinical Microbiology and Infection, 2021
Carolina Venditti, Carla Fontana, Francesco Messina   +2 more
exaly  

Cross-resistance to cefiderocol and ceftazidime–avibactam in KPC β-lactamase mutants and the inoculum effect

Clinical Microbiology and Infection, 2021
Claire Amaris Hobson, Olivier Tenaillon, André Birgy   +2 more
exaly  

Emergence of ceftazidime/avibactam resistance in carbapenem-resistant Klebsiella pneumoniae in China

Clinical Microbiology and Infection, 2020
Xueqing Wu
exaly  

Ceftazidime/Avibactam Sodium

2020
openaire   +1 more source

Ceftazidime-Avibactam Is Superior to Other Treatment Regimens against Carbapenem-Resistant Klebsiella pneumoniae Bacteremia

Antimicrobial Agents and Chemotherapy, 2017
Ryan K Shields, M Hong Nguyen, Liang Chen   +2 more
exaly  

Clinical Outcomes, Drug Toxicity, and Emergence of Ceftazidime-Avibactam Resistance Among Patients Treated for Carbapenem-Resistant Enterobacteriaceae Infections: Table 1.

Clinical Infectious Diseases, 2016
Ryan K Shields, Ghady Haidar, Yohei Doi
exaly  

Ceftazidime Avibactam

Stephanie J. Phelps, Tracy M. Hagemann, Kelley R. Lee   +2 more
openaire   +1 more source

Ceftazidime-avibactam Versus Doripenem for the Treatment of Complicated Urinary Tract Infections, Including Acute Pyelonephritis: RECAPTURE, a Phase 3 Randomized Trial Program

Clinical Infectious Diseases, 2016
Jack D Sobel, Gregory G Stone
exaly